Just when 100 percent of our medical staff have received the booster dose with Abdala, the population over 19 years of age in the Guantánamo municipality receives the same dose (the fourth in this case) to strengthen the body's defenses against the risk that implies the appearance of new variants of COVID-19.
The hundreds of clinical sites enabled for the vaccination of all citizens, which began in July 2021, now also host this stage, which as a requirement requires having the primary three-dose scheme, and that three months have elapsed since the last administration.
A few days ago a large number of Guantanamo residents came to be inoculated with the first vaccine produced in Latin America and the Caribbean, and the student community of the Guantanamo Medical University was at the forefront, which, like professionals in the field, remained very active, with important missions within the confrontation with the difficult epidemiological period.
The booster dose will also be available to residents who arrive in the country with some of the internationally existing immunogens, provided they have six months from the final inoculation. Those interested may be vaccinated in the International Medical Services consultations of the Guantánamo Hotel or in the Martí, although a specific position is foreseen for that task.
At the moment, those under 18 years of age will not be vaccinated, nor those suffering from decompensated chronic or active oncological diseases, as well as patients with hypersensitivity to the vaccine compounds, nor those suffering from an acute infectious disease at the time of application, who They will be able to do it 15 days after discharge.
In the case of those who are injected with Soberana Plus, they must wait 6 months to receive the booster, which may be with any of the Cuban vaccine candidates.
Guantánamo has evidence that protection against resistant variants of the virus is greater as the level of antibodies increases, and the booster dose that is administered now guarantees the selection of memory clones and a longer duration of the immune response to any threat from SARSCOV2.
Dairon Martínez Tejeda
Read more...